| |
| |
|
| Insider
Information: |
Alphabet Inc. |
| Relationship: |
10% Owner |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
31,942,641 |
|
|
Indirect Shares
|
73,738,852 |
|
|
| Direct
Value |
$60,691,018 |
|
|
|
Indirect Value
|
$278,911,470 |
|
|
| Total
Shares |
105,681,493 |
|
|
| Total
Value |
$339,602,488 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
12
|
23
|
|
Stock
price went up :
|
11
|
17
|
| Stock
price went down : |
1
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
11.0
|
2.8
|
| Percentage
Gain/Loss : |
 65.7%
|
1,898.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arcus Biosciences Inc |
RCUS |
10% Owner |
2018-03-19 |
0 |
2018-03-19 |
1,924,474 |
Premium* |
|
|
X4 Pharmaceuticals Inc |
XFOR |
10% Owner |
2017-11-20 |
0 |
2017-11-20 |
451,362 |
Premium* |
|
|
Armo Biosciences Inc |
ARMO |
10% Owner |
2018-01-30 |
0 |
2018-01-30 |
607,350 |
Premium* |
|
|
Dianthus Therapeutics Ord Shs |
DNTH |
10% Owner |
2018-06-25 |
0 |
2018-06-25 |
3,339,137 |
Premium* |
|
|
Crowdstrike Holdings, Inc. |
CRWD |
10% Owner |
2019-06-14 |
0 |
2020-02-20 |
140,000 |
Premium* |
|
|
Duolingo, Inc. |
DUOL |
10% Owner |
2021-07-30 |
0 |
2021-07-30 |
0 |
Premium* |
|
|
Freshworks Inc. |
FRSH |
10% Owner |
2021-11-16 |
0 |
2021-11-22 |
2,094,204 |
Premium* |
|
|
Planet Labs PBC |
PL |
10% Owner |
2021-12-07 |
31,942,641 |
|
0 |
Premium* |
|
|
Ionq Ord Shs |
IONQ |
10% Owner |
|
0 |
2022-04-11 |
0 |
Premium* |
|
|
Gitlab Inc. |
GTLB |
Member of 10% Group |
2022-05-10 |
0 |
2023-05-05 |
2,647,312 |
Premium* |
|
|
Prime Medicine, Inc. |
PRME |
10% Owner |
2022-10-24 |
0 |
2024-02-20 |
3,200,000 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
|
2022-10-31 |
0 |
2023-12-01 |
1,800,000 |
Premium* |
|
|
Insynergy Products, Inc |
ISYG |
10% Owner |
|
0 |
2023-02-15 |
57,535,013 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
142 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-13 |
4 |
AS |
$15.13 |
$425,102 |
I/I |
(28,100) |
0 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-13 |
4 |
AS |
$0.00 |
$0 |
I/I |
(28,100) |
10,258,617 |
0 |
% |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-02 |
4 |
AS |
$0.00 |
$0 |
I/I |
(28,651) |
6,206,594 |
0 |
- |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-14 |
4 |
AS |
$14.87 |
$430,684 |
I/I |
(28,960) |
0 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-14 |
4 |
AS |
$0.00 |
$0 |
I/I |
(28,960) |
10,229,657 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-06 |
4 |
AS |
$17.02 |
$510,166 |
I/I |
(29,975) |
0 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-06 |
4 |
AS |
$0.00 |
$0 |
I/I |
(29,975) |
10,338,420 |
0 |
% |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-01 |
4 |
AS |
$0.00 |
$0 |
I/I |
(31,963) |
6,235,245 |
0 |
- |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-20 |
4 |
AS |
$15.06 |
$563,248 |
I/I |
(37,405) |
0 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-20 |
4 |
AS |
$0.00 |
$0 |
I/I |
(37,405) |
10,119,061 |
0 |
% |
|
| CRWD |
Crowdstrike Holdings, Inc... |
10% Owner |
– – • |
2020-02-05 |
4 |
S |
$63.99 |
$2,459,522 |
I/I |
(38,429) |
0 |
0 |
% |
|
| CRWD |
Crowdstrike Holdings, Inc... |
10% Owner |
– – • |
2020-02-05 |
4 |
A |
$0.00 |
$0 |
I/I |
38,429 |
38,429 |
0 |
- |
|
| GTLB |
Gitlab Inc. |
Member of 10% Group |
– – – |
2022-11-08 |
4 |
B |
$35.97 |
$1,428,187 |
I/I |
39,423 |
1,112,215 |
0.01 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-05-23 |
4 |
AS |
$14.74 |
$647,648 |
I/I |
(43,939) |
0 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-05-23 |
4 |
AS |
$0.00 |
$0 |
I/I |
(43,939) |
10,513,153 |
0 |
% |
|
| FRSH |
Freshworks Inc. |
Director |
– • – |
2021-11-16 |
4 |
S |
$39.14 |
$1,726,074 |
I/I |
(44,100) |
0 |
0 |
% |
|
| FRSH |
Freshworks Inc. |
Director |
– • – |
2021-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
44,100 |
22,885 |
0 |
- |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-01 |
4 |
AS |
$14.35 |
$649,194 |
I/I |
(45,223) |
0 |
0 |
% |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-06-01 |
4 |
AS |
$0.00 |
$0 |
I/I |
(45,223) |
10,390,829 |
0 |
% |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-04 |
4 |
AS |
$0.00 |
$0 |
I/I |
(48,583) |
6,108,442 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-11-03 |
4 |
AS |
$0.00 |
$0 |
I/I |
(49,569) |
6,157,025 |
0 |
- |
|
| PRME |
Prime Medicine, Inc. |
10% Owner |
– – • |
2023-05-16 |
4 |
AS |
$12.59 |
$637,676 |
I/I |
(50,649) |
10,750,324 |
0 |
% |
|
| FRSH |
Freshworks Inc. |
Director |
– • – |
2021-11-17 |
4 |
A |
$0.00 |
$0 |
I/I |
51,522 |
26,736 |
0 |
- |
|
| FRSH |
Freshworks Inc. |
Director |
– • – |
2021-11-17 |
4 |
S |
$39.08 |
$2,013,480 |
I/I |
(51,522) |
0 |
0 |
% |
|
| VERV |
Verve Therapeutics, Inc. |
Member of 10% Group |
– – – |
2022-10-31 |
4 |
AS |
$0.00 |
$0 |
I/I |
(53,697) |
6,267,208 |
0 |
- |
|
142 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
